Workers inspect the performance of equipment at the workshop of Novo Nordisk (China) Pharmaceutical Co., Ltd. in Tianjin, north China, Feb. 25, 2020. The Binhai New District in Tianjin has made efforts to support foreign-funded enterprises to resume production during the fight against the novel coronavirus disease (COVID-19). (Xinhua/Li Ran)
